Work

Supplementary Figures 1 - 6 from Cidofovir: A Novel Antitumor Agent for Glioblastoma

Year: 2023

Type: supplementary-materials

Abstract: PDF file - 508K, Figure S1. CDV treatment inhibits viral gene expression in a primary GBM, endogenously infected with HMCV. Figure S2. Control to viability of U87MG after infection with HCMV. Figure S3. Treatment with Cidofovir inhibits global HCMV gene expression. Figure S4. SF7796 primary derived GBM (used for in vivo experiments) is endogenously infected with HCMV. Figure S5. Treatment of normal and tumor cells with CDV in vitro. Figure S6. CDV treatment significantly suppresses the expression of HCMV in established human SF7796 xenografts in vivo.

DOI: 10.1158/1078-0432.22449608.v1

Authors: Piotr Hadaczek, Tomoko Ozawa, Liliana Soroceanu, Yasuyuki Yoshida, Lisa Matlaf, Eric Singer, Estefania Fiallos, C. David James, Charles S. Cobbs

Language: English

Topic: Cytomegalovirus and herpesvirus research

Subfield: Epidemiology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: gold

OpenAlex ID: W4361908314

Cites:

Cited by:

Related to: 10